Skip to main content
Clinical Trials/NCT01468597
NCT01468597
Completed
Not Applicable

Does Platelet Inhibition Predict Surgery Related Bleeding in Patients Undergoing Emergent Cardiac Surgery During Dual Antiplatelet Therapy - a Pilot Study

Medical University of Graz1 site in 1 country167 target enrollmentJanuary 2011
ConditionsBleeding

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Bleeding
Sponsor
Medical University of Graz
Enrollment
167
Locations
1
Primary Endpoint
Calculated Blood Loss
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The aim of the study is to evaluate if there is an association between platelet inhibition and surgery-related bleeding in patients undergoing emergent cardiac surgery during dual antiplatelet therapy.

Detailed Description

Blood for measuring platelet function is drawn before induction of anesthesia

Registry
clinicaltrials.gov
Start Date
January 2011
End Date
August 2014
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Medical University of Graz
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • First time on-pump CABG with or without valve replacement

Exclusion Criteria

  • Redo surgery,
  • Renal insufficiency needing dialysis,
  • Concomitant medication with warfarin,
  • Preoperative fibrinogen \< 150 mg%

Outcomes

Primary Outcomes

Calculated Blood Loss

Time Frame: until postoperative day 5

Secondary Outcomes

  • BARC Bleeding(until postoperative day 2)

Study Sites (1)

Loading locations...

Similar Trials